Oncology Companion Diagnostic Market Size, Share & Trends Report

Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (IHC, NGS), By Disease Type (Breast Cancer, Leukemia), By End Use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-049-7
Number of Pages: 183
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Oncology Companion Diagnostic Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
- Product
  - Instrument
  - Consumables
  - Software
- Service
Oncology Companion Diagnostic Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Polymerase chain reaction (PCR)
- Next-generation sequencing (NGS)
- Immunohistochemistry (IHC)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Other technologies
Oncology Companion Diagnostic Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
- Breast cancer
- Non-small cell lung cancer
- Colorectal cancer
- Leukemia
- Melanoma
- Prostate cancer
- Others
Oncology Companion Diagnostic End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital
- Pathology/Diagnostic laboratory
- Academic medical center
Oncology Companion Diagnostic Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
    - Product
    - Instrument
    - Consumables
    - Software
    - Service
  - North America Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Polymerase chain reaction (PCR)
    - Next-generation sequencing (NGS)
    - Immunohistochemistry (IHC)
    - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    - Other technologies
  - North America Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast cancer
    - Non-small cell lung cancer
    - Colorectal cancer
    - Leukemia
    - Melanoma
    - Prostate cancer
    - Others
  - North America Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospital
    - Pathology/Diagnostic laboratory
    - Academic medical center
  - U.S.
    - U.S. Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - U.S. Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - U.S. Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - U.S. Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Canada
    - Canada Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Canada Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Canada Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Canada Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
- Europe
  - Europe Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
    - Product
    - Instrument
    - Consumables
    - Software
    - Service
  - Europe Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Polymerase chain reaction (PCR)
    - Next-generation sequencing (NGS)
    - Immunohistochemistry (IHC)
    - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    - Other technologies
  - Europe Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast cancer
    - Non-small cell lung cancer
    - Colorectal cancer
    - Leukemia
    - Melanoma
    - Prostate cancer
    - Others
  - Europe Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospital
    - Pathology/Diagnostic laboratory
    - Academic medical center
  - UK
    - UK Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - UK Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - UK Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - UK Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Germany
    - Germany Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Germany Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Germany Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Germany Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - France
    - France Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - France Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - France Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - France Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Italy
    - Italy Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Italy Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Italy Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Italy Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Spain
    - Spain Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Spain Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Spain Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Spain Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Sweden
    - Sweden Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Sweden Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Sweden Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Sweden Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Norway
    - Norway Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Norway Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Norway Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Norway Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Denmark
    - Denmark Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Denmark Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Denmark Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Denmark Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
- Asia Pacific
  - Asia Pacific Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
    - Product
    - Instrument
    - Consumables
    - Software
    - Service
  - Asia Pacific Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Polymerase chain reaction (PCR)
    - Next-generation sequencing (NGS)
    - Immunohistochemistry (IHC)
    - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    - Other technologies
  - Asia Pacific Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast cancer
    - Non-small cell lung cancer
    - Colorectal cancer
    - Leukemia
    - Melanoma
    - Prostate cancer
    - Others
  - Asia Pacific Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospital
    - Pathology/Diagnostic laboratory
    - Academic medical center
  - China
    - China Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - China Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - China Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - China Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Japan
    - Japan Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Japan Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Japan Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Japan Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - India
    - India Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - India Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - India Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - India Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Australia
    - Australia Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Australia Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Australia Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Australia Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Thailand
    - Thailand Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Thailand Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Thailand Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Thailand Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - South Korea
    - South Korea Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - South Korea Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - South Korea Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - South Korea Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
- Latin America
  - Latin America Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
    - Product
    - Instrument
    - Consumables
    - Software
    - Service
  - Latin America Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Polymerase chain reaction (PCR)
    - Next-generation sequencing (NGS)
    - Immunohistochemistry (IHC)
    - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    - Other technologies
  - Latin America Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast cancer
    - Non-small cell lung cancer
    - Colorectal cancer
    - Leukemia
    - Melanoma
    - Prostate cancer
    - Others
  - Latin America Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospital
    - Pathology/Diagnostic laboratory
    - Academic medical center
  - Brazil
    - Brazil Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Brazil Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Brazil Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Brazil Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Mexico
    - Mexico Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Mexico Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Mexico Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Mexico Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Argentina
    - Argentina Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Argentina Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Argentina Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Argentina Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
- Middle East and Africa
  - Middle East and Africa Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
    - Product
    - Instrument
    - Consumables
    - Software
    - Service
  - Middle East and Africa Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Polymerase chain reaction (PCR)
    - Next-generation sequencing (NGS)
    - Immunohistochemistry (IHC)
    - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    - Other technologies
  - Middle East and Africa Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast cancer
    - Non-small cell lung cancer
    - Colorectal cancer
    - Leukemia
    - Melanoma
    - Prostate cancer
    - Others
  - Middle East and Africa Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospital
    - Pathology/Diagnostic laboratory
    - Academic medical center
  - Saudi Arabia
    - Saudi Arabia Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Saudi Arabia Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Saudi Arabia Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Saudi Arabia Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - South Africa
    - South Africa Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - South Africa Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - South Africa Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - South Africa Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - UAE
    - UAE Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - UAE Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - UAE Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - UAE Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center
  - Kuwait
    - Kuwait Oncology Companion Diagnostic Market, Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
      - Product
      - Instrument
      - Consumables
      - Software
      - Service
    - Kuwait Oncology Companion Diagnostic Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Polymerase chain reaction (PCR)
      - Next-generation sequencing (NGS)
      - Immunohistochemistry (IHC)
      - In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      - Other technologies
    - Kuwait Oncology Companion Diagnostic Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast cancer
      - Non-small cell lung cancer
      - Colorectal cancer
      - Leukemia
      - Melanoma
      - Prostate cancer
      - Others
    - Kuwait Oncology Companion Diagnostic Market, End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospital
      - Pathology/Diagnostic laboratory
      - Academic medical center

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.